Abiopharma

New Form 3 - Nuvalent, Inc. Filed: 2025-06-20 AccNo: 0000950170-25-088543 Size: 17 KB

New Form 4 - Liquidia Corp Filed: 2025-06-20 AccNo: 0001104659-25-061188 Size: 4 KB

New Form S-8 POS - Kronos Bio, Inc. Filed: 2025-06-20 AccNo: 0001140361-25-023191 Size: 25 KB

New Form S-8 POS - Kronos Bio, Inc. Filed: 2025-06-20 AccNo: 0001140361-25-023189 Size: 25 KB

New Form S-3 - Jaguar Health, Inc. Filed: 2025-06-20 AccNo: 0001193125-25-143699 Size: 453 KB

New Form 8-K - Quoin Pharmaceuticals, Ltd. Filed: 2025-06-20 AccNo: 0001104659-25-061184 Size: 190 KB Item 8.01: Other Events

New Form 4 - Liquidia Corp Filed: 2025-06-20 AccNo: 0001104659-25-061186 Size: 4 KB

New Form 4 - Schrodinger, Inc. Filed: 2025-06-20 AccNo: 0001490978-25-000087 Size: 7 KB

Update on FDA Review of Ruxolitinib Cream(Opzelura®) for Children Ages 2-11 with Atopic Dermatitis

Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

New Form 4 - Addus HomeCare Corp Filed: 2025-06-20 AccNo: 0000950170-25-088536 Size: 4 KB

New Form 4 - Addus HomeCare Corp Filed: 2025-06-20 AccNo: 0000950170-25-088540 Size: 4 KB

New Form 8-K - 180 Life Sciences Corp. Filed: 2025-06-20 AccNo: 0001213900-25-056232 Size: 247 KB Item 3.02: Unregistered Sales of Equity Securities Item 8.01: Other Events

New Form 4 - Liquidia Corp Filed: 2025-06-20 AccNo: 0001104659-25-061183 Size: 4 KB

New Form 4 - Addus HomeCare Corp Filed: 2025-06-20 AccNo: 0000950170-25-088537 Size: 4 KB